Tendersinfo keep you informed about the latest events in the national and international Procurement Industry. Procurement News provides in-depth coverage of the procurement industry, including contract awards, contract additions, new contract wins, mergers and acquisitions. Tendersinfo through its tender news section provides an update on all domestic and global tendering opportunities, invitation to bid & trade leads.

Publish Date : 25-Mar-2019

Following the announcement by the South African National Treasury Department regarding the results of the South African Governments National Anti-Retroviral (ARV) Tender on 14 February 2019, Adcock Ingram is delighted to announce that it has been successful in winning a number of key products within the tender. Adcock Ingram has been awarded a 12% share of the ARV tender, equating to approximately R1.8 billion (excluding VAT) to supply ARV drugs to state-run hospitals, over a period of three years, effective from 1 July 2019.

The Company submitted bids for the triple combination products, Tenofovir/Emtricitabine/Efavirenz (TEE) and Dolutegravir/Lamivudine/Tenofovir (DLT), as well as a number of the dual and monotherapy molecules. Adcock Ingrams share of the ARV Tender award over the three years includes 11% (16.8 million packs) of the 147 million packs of DLT requested in the tender, 2.8 million packs of other oral solid dosage products and 2.7 million bottles of oral solutions.

As a member of Proudly South Africa, Adcock Ingram has its roots firmly entrenched in the South African market. We are proud to be a leading South African manufacturer, which has been recognised as a partner of the State in the national fight against HIV and AIDS. The tender award reflects positively on our manufacturing capability, breadth of our product offering and our historical service delivery levels. Our investment into the oral solid dosage facility situated in Wadeville has increased our ability to manufacture and supply antiretroviral medicines to the public sector through the tender system, and also meet the needs of the private healthcare market.

Adcock Ingram is proud to have been chosen as one of the States partners in the fight against one of the biggest epidemics in the world. As a responsible South African manufacturer and supplier of ARVs, our business model is focused firmly within our ethos of Adding Value to Life and in line with our quest to advance affordable healthcare for all South Africans. We look forward to continuing this partnership with government united in the fight against AIDS says Ashley Pearce, Managing Director: Adcock Ingram Prescription Division.

Go to previous page